Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis.
J Eur Acad Dermatol Venereol
; 36(7): e574-e576, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35279885
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
Limits:
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Year:
2022
Document type:
Article